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Abstract
Background: The purpose of this survey was to evaluate the performance of hypertension screening in medical
institutions conducting the national general health screening program of the Republic of Korea.
Methods: We contacted 700 medical institutions of Seoul and Incheon areas which performed the national general
health screening program in 2016, and 210 of them completed telephone survey. The questions asked in the survey
include equipment, environment, personnel and quality control procedures for blood pressure (BP) measurement, and
interpretation of the measurements.
Results: A majority of the responding screening centers used oscilloscope sphygmomanometers (51.9%), had
only one-sized cuff (65.2%), and measured BP in open space (54.3%). BP levels were measured mainly by nurses
(62.0%) and doctors (25.0%), after a 1 to10 minutes (84.9%) of resting period. A 75.2% of screening centers regularly
calibrated sphygmomanometers, 81.4% had a manual for BP measurement, and 59.0% had a training program. A 80.0%
of respondents answered that they used averages of multiple BP measurements to determine an individual’s BP level,
and 82.9% answered that criteria for hypertension was systolic BP ≥140 mmHg and/or diastolic BP ≥ 90 mmHg. If a
screening finds an individual with hypertension, 82.9% of centers recommend revisiting for a second BP measurement
rather than start medication immediately.
Conclusion: In most medical institutions performing general health screening program, certified medical personnel
measure BP and interpret the results according to established protocols. However, there is room for improvement in
the equipment, environment and quality control procedures for BP measurement.
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Background
Hypertension, the most important modifiable risk factor
for cardiovascular diseases, is a major health burden and
the leading cause of death in the worldwide [1–4]. Previ-
ous studies reported that the reduction of highly or
moderately elevated BP levels results in a decrease in
stroke and myocardial infarction rates [5, 6]. Every
10 mmHg increase in systolic blood pressure (BP) or
diastolic BP is estimated to double the risk of death from
ischemic heart disease and stroke [7].
In Korea, diseases of circulatory system including cor-
onary heart disease and stroke accounted for 22% of the
entire death in 2015 [8]. The number of people who
visited the hospital for chronic diseases in 2015 was
14.39 million, with the highest number of hypertension
(5.71 million) among them in Korea. Prevalence of hyper-
tension was estimated to about 35.1% for male, and 29.1%
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for female among Korean adults aged 30 years and above
in 2015 [9]. According to the Korean Nation Health Sur-
vey in 2001, the age-adjusted prevalence of hypertension
was 22.9% (26.9% in men and 20.5% in women) [10]. Espe-
cially, hypertension is a common disease among Korean
elderly population aged 65 years or older considering that
its prevalence increased between 2007 and 2011 from
49.3% to 58.4% in men and from 61.8% to 68.9% in
women [11]. Total medical cost for hypertension was esti-
mated to 2850 billion Korean won (KRW) which accounts
for 13.4% of medical cost due to all chronic disorders [12].
This means that controlling hypertension is crucial to
reducing the overall burden of disease in society and im-
proving quality of life. Therefore, many countries carry
out national health screening and emphasize the import-
ance of measuring BP. The benefits of screening for
hypertension are well established [13–15]. However,
although hypertension screening is a very important for
preventing of hypertension, there have been few studies
on hypertension screening in Korea. Thus, we evaluated
the performance of hypertension screening and interpret-
ation of BP measurements in medical institutions per-
forming the national general health screening program of
the Republic of Korea.
Methods
This descriptive survey aims to collect information on
protocol of BP measurement, setting condition of meas-
urement place, diagnosis of hypertension, and criteria of
medicine prescription. First, we made a multiple-choice
questionnaire to conduct a survey using telephone. The
survey was conducted by trained telephone interviewers
for February and March of 2016. A total of 5435 medical
institutions, including clinics, general hospital, long-term
care hospital, hospitals, and health center, were able to
conduct surveys in 2016. We contacted 700 medical in-
stitutions of Seoul and Incheon areas which performed
the national general health screening program in 2016,
and 210 of them completed telephone survey. We made
questionnaire items based on hypertension screening
protocol of Korea National Health Insurance [16] with
reviewing seventh and eighth report of the Joint Na-
tional Committee (JNC) [17, 18], and 2013 guidelines on
hypertension of the European Society of Hypertension
and the European Society of Cardiology (ESH/ESC) [19].
According to protocol for BP measurement in national
health screening program, all examinees had rested for
at least 5 min in a seated position prior to first measure-
ment. BP should be measured by the auscultation
method using a stethoscope or using an oscilloscopic
automatic sphygmomanometer in a quiet environment.
The calibration of devices should be checked day-to-day.
A cuff with an appropriately sized bladder should be
used. The standard bladder for adults is 12 cm wide and
26 cm long. The use of a bladder with a width of at least
40% of the circumference of the arm and a length of
80% to 100% of the circumference of the arm is recom-
mended. Examinees are recommended to avoid smoking,
alcohol, or caffeine before measurement. We made the
questionnaire items reflecting these protocols.
Results
A 210 responding medical institutions includes 154
clinics, 38 hospitals, 15 general hospitals, 2 long-term
care hospitals, and 1 health check-up center (Table 1).
Most screening centers (51.9%) used oscilloscope sphyg-
momanometer to measure BP, and the percentage of
medical institutions using only mercury sphygmoma-
nometers was 44%. A 75.2% of medical institutions re-
gularly check whether sphygmomanometers operate
normally. A 65.2% of the medical institutions had only
one cuff size, and 40.5% said they use a thermometer. A
majority of the screening centers used open space
(54.3%) to measure BP and 28.6% of the medical institu-
tions used an independent place for BP measurement
only. People who measure BP were mainly the nurse
(62%) and the doctor (25%).
BP was measured twice or more in 59.5% of medical
institutions, and 35.2% of medical institution measured
BP only one time (Table 2). A 18.6% of the medical insti-
tutions did not have manual to measure BP and 40.5%
did not perform the BP measurement training. A major-
ity of the medical institutions (93.8%) did not measure
the arm circumference to select the appropriate cuff size.
A 94.8% of medical institutions said they would let
people take a rest before measuring BP, and 5% said they
did not give people time to relax.
In the majority of medical institutions (82.9%), the def-
inition of hypertension was systolic BP ≥ 140 mmHg or
diastolic BP ≥ 90 mmHg (Table 3). A 56.2% of the med-
ical institutions applied different diagnostic criteria for
hypertension according to sex, age, and accompanying
diseases. When an examinee has high blood pressure at
first visit, the most common strategy is recommendation
to revisit after 1 to 2 weeks to measure BP again.
Table 4 is as to which levels of the patient’s BP a doctor
decided to treatment. The majority of medical institutions
prescribe medication when an examinee has at least above
systolic BP of 150 mmHg considering remeasured BP
together (Table 4). When the examinee had a systolic BP
of 140 mmHg and a diastolic BP of 80 mmHg, 57.1% of
medical institutions did not recommend the use of anti-
hypertensive medication, and 39.5% of medical institutions
recommended medication. When the examinee had a
systolic BP of 150 mmHg and a diastolic BP of 95 mmHg,
16.7% of the medical institutions did not recommend the
use of anti-hypertensive medication, and 79.5% of medical
institutions recommended medication. A total of 171
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Table 1 Physical and human resources related to blood pressure measurement
Classification n (%)
Type of medical institution
Clinic 154 (73.3)
Hospital 38 (18.1)
General hospital 15 (7.1)
Long-term care hospital 2 (1.0)
Health check-up center 1 (0.5)
Type of sphygmomanometer
Oscilloscope 109 (51.9)
Mercury 44 (21.0)
Aneroid 1 (0.5)
Mercury and oscilloscope 50 (23.8)
Aneroid and oscilloscope 5 (2.4)
Mercury, aneroid and oscilloscope 1 (0.5)
Cuff size
One 137 (65.2)
Two 66 (90.4)
Three or more 7 (9.6)
Existence of a thermometer
Yes 85 (40.5)
No 125 (59.5)
Sphygmomanometer calibration before measurement
Yes 158 (75.2)
Daily 75 (47.5)
Weekly 43 (27.2)
Monthly 39 (24.7)
No response 1 (0.6)
No 52 (24.8)
Place of blood pressure measurement
Open space (e.g. waiting room, reception desk and lobby) 114 (54.3)
Separate room for measurement of blood pressure 60 (28.6)
Separate room for measurements of blood pressure and other examinations 18 (8.6)
Open space or separate room 16 (7.6)
No specified place 1 (0.5)
No response 1 (0.5)
Person who measure blood pressure
Nurse 130 (62.0)
Physician 53 (25.0)
Medical technician 14 (7.0)
Nurse’s aide 10 (5.0)
Administrative staff 2 (1.0)
Examinee (automated measurement) 1 (0.0)
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(81.4%) medical institutions were considering examinees’
sex, age, and accompanying diseases when they re-
commended anti-hypertensive medication to examinees.
However, the majority of the screening institutions recom-
mended medication, regardless of age, at least 150 mmHg
levels of systolic BP.
Discussion
We evaluated the performance of hypertension screen-
ing and interpretation of BP measurements in medical
institutions performing the national general health
screening program in Korea. The JNC-8 and 2013 ESH/
ESC as well as Korean Society of Hypertension recom-
mend age-differential BP goal and treatment strategies
[11, 17, 19]. The guideline for BP measurement and in-
terpretation in Korea hypertension screening program is
no different from these international guidelines.
Diagnosis of hypertension is commonly made from
hypertension screening because hypertension has no
specific symptoms. Hypertension can be diagnosed by
noninvasive BP measurement and controlled by lifestyle
changes or drugs, so it is a main target condition of na-
tional health screening. The benefits of screening for
hypertension have been reported in previous studies.
Systematic reviews support the effectiveness of BP
screening of adults to detect hypertension and treat
them to reduce cardiovascular disease [13]. A
population-based cohort study in England reported that
reductions in cardiovascular risk factor values were ob-
served in people who regularly received the national
health check-up [14]. A retrospective cohort study in
Taiwan also reported that nationwide periodic health ex-
aminations was effective in promoting early treatment of
hypertension, diabetes and hyperlipidemia in adults aged
≥40 years [15].
In Korea, the national health screening program con-
trolled by government in nationwide level was launched
in 1980. There are general screening program, national
screening program for people at transitional age (44
and 66 years old), cancer screening, and infant
screening program. Korea is investing more than 700
billion KRW in the national health examination, and
many large private medical institutions are expanding
their screening competitively in national screening
area [20].
Several previous studies evaluated overall status of the
national general health screening program, and sug-
gested some points to be improved [20, 21]. However,
Table 2 Methods of measuring blood pressure and related
resources
Number Percent
Number of measurement
Once 74 (35.2)
Twice 109 (51.9)
Triple or more 16 (7.6)
Etc. 11 (4.2)
Existence of a manual
Yes 171 (81.4)
No 39 (18.6)
Existence of an operator training program
Yes 124 (59.0)
No 85 (40.5)
No response 1 (0.5)
Measurement of arm circumference
Yes 12 (5.7)
No 197 (93.8)
No response 1 (0.5)
Resting time before measurement
Yes 199 (94.8)
1–10 min 169 (84.9)
11–20 min 22 (10.5)
21–30 min 8 (4.0)
No 11 (5.2)
Table 3 The criteria related to hypertension by medical
institutions participated in the survey
Number Percent
Use the average of multiple measurements to determine an individual’s
BP level
Yes 168 (80.0)
No 42 (20.0)
Definition of hypertension for people younger than 65 years
SBP ≥ 130 mmHg or DBP ≥ 90 mmHg 21 (10.0)
SBP ≥ 140 mmHg or DBP ≥ 90 mmHg 174 (82.9)
SBP ≥ 160 mmHg or DBP ≥ 90 mmHg 8 (3.8)
No response 7 (3.3)
Use different hypertension criteria according to sex, age, and
accompanying disease
Yes 118 (56.2)
No 92 (43.8)
Definition of hypertension for people older than 65 years (n = 118)
SBP ≥ 130 mmHg or DBP ≥ 90 mmHg 9 (7.6)
SBP ≥ 140 mmHg or DBP ≥ 90 mmHg 83 (70.3)
SBP ≥ 160 mmHg or DBP ≥ 90 mmHg 20 (16.9)
No response 6 (5.1)
Recommendation for people with high blood pressure
Revisit and measure blood pressure again 174 (82.9)
24-h ambulatory blood pressure measurement 17 (8.1)
Prescription anti-hypertensive drug 16 (7.6)
No response 3 (1.4)
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there is no available study which specifically evaluated
the performance of BP measurement and interpretation
in the national general health screening program in
Korea. Screening for hypertension is the most important
and cost-effective component of the general health
screening, but only limited data are available on specific
condition and performance of hypertension screening.
As we mentioned above, hypertension can be effectively
detected and prevented through measurement of blood
pressure, and proper treatment of high blood pressure
can prevent cardiovascular events. However, if the qual-
ity of BP measurement is poor, interpretation of BP
measurement is also not good and proper treatment
is not possible. We hope that our report will be used
as the baseline data for evaluating and improving the
performance of national hypertension screening,
because it is the first study on the actual status of BP
measurement and interpretation of the national
general health screening program.
The current study has some limitations. First, this
study was a telephone survey that relies on self-report
data and had a relatively small sample size. There is no
assurance that the self-reported performance of hyper-
tension screening and interpretation of BP measure-
ments reflect real situation and an aspect of quality
control. The self-reported data also may be influenced
by the mode of administration of the questionnaire
which can affect response rate or response contents [22].
Second, this study included medical institutions only in
Seoul and Incheon areas, not in the whole country.
Therefore, it may not be appropriate to generalize the
present results to the entire. A third limitation is the po-
tential for non-responder bias. It is possible that medical
institutions with poor hypertension screening perform-
ance are less likely to participate in a telephone survey.
Conclusions
In summary, the medical institutions performing the
national general health screening program used mainly
oscilloscopic devices for BP measurement, and most of
them had measurement manuals and training protocols.
Majority of the institutions measured BP multiple times
with a resting period, and used the average values to
determine an individual’s BP level. However, there is room
for improvement in the equipment, environment and
quality control procedures for BP measurement of the
Korea national general health screening program.
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